铁素还原酶和有机金属复合物:一个关键系统来解决多药耐药性瘤?
Michèle Salmain1, Marie Gaschard1, Milad Baroud2
1Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire (IPCM), 4 Place Jussieu, F-75005 Paris, France.
Cancers
|September 28, 2023
概括
多抗药性 (MDR) 癌症的治疗具有挑战性. 本综述探讨了氨酸减少酶 (TrxR) 抑制剂,包括黄金复合物,作为对MDR瘤的有前途的多重向策略.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 生物化学 生化学
背景情况:
- 耐多药性 (MDR) 癌症具有严重的临床挑战,预后不佳.
- 抵抗机制涉及瘤细胞及其微环境,需要多重向的治疗策略.
研究的目的:
- 审查氨酸减少酶 (TrxR) 抑制作为MDR瘤治疗策略的作用.
- 检查无机和有机金属金复合物,以及金属,作为TrxR抑制剂.
主要方法:
- 对TrxR抑制剂研究的文献综述.
- 分析各种金属复合体对TrxR抑制的分子机制.
- 讨论TrxR抑制和细胞毒性之间的关系.
主要成果:
- 奥拉诺芬是一种强大的无机金复合体抑制剂TrxR.
- 有机金属复合物,包括黄金 (I),黄金 (III) 和金属 (Fe, Os),也表现出TrxR抑制活性.
- 在这些复合体中,TrxR抑制机制的相似性和差异被确定.
结论:
- TrxR抑制是针对MDR瘤的一个有希望的策略.
- 各种黄金复合物和金属烯显示出作为TrxR抑制剂的潜力.
- 需要进一步研究TrxR抑制和细胞毒性之间的关系.
关键词:
这是一种N-异环碳化合物.黄金金 (Auranofin) 是一种癌症 癌症 癌症 癌症 癌症铁烯酸铁烯酸铁烯酸铁烯酸是什么黄金 黄金 黄金 黄金 黄金有机金属复合体有机金属复合体铁素还原酶是一种 thioredoxin.更多相关视频
相关概念视频
Electron Transport Chain: Complex I and II
14.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.3K
The Electron Transport Chain
16.9K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
The Supercomplexes in the Crista Membrane
2.5K
The mitochondrial cristae membrane is the primary site for the oxidative phosphorylation (OXPHOS) process of energy conversion mediated through respiratory complexes I to V. These complexes have been widely studied for decades, and it has been proven that they form supramolecular structures called respiratory supercomplexes (SC). These higher-order complexes may be crucial in maintaining the biochemical structure and improving the physiological activity of the individual complexes while...
2.5K
Electron Transport Chain: Complex III and IV
7.6K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
7.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


